• Hybrid iontophoresis system allows clinicians to choose the right medication and right application for every patient
• Designed to help break down the skin’s resistance, the transdermal patch safely administers medicine for quick pain relief
• Features built-in batteries plus dose controller activation to allow for quick and effective application
• I-Bresis delivers the patient greater benefit from each treatment, ensuring more medication reaches the target tissue

Time-Saving Treatment Options

I-Bresis Hybrid Iontophoresis System is designed to accelerate drug delivery through hybrid iontophoresis technology. The wireless device applies direct current drives penetration by opening pathways to the skin. It powers a 3-minute skin conductivity enhancement to help break down the skin’s resistance, resulting in a 40-80 mA-min treatment in approximately 1-2 hours.

Active Delivery to Accelerate Recovery

Compared to passive delivery, I-Bresis Patches deliver the patient greater benefit from each treatment, ensuring more medication reaches the target tissue. Includes three treatment modes and the ability to deliver medication with positive or negative polarity. The disposable, single-use patch features built-in batteries plus dose controller activation allows quick and effective application.

Charging Station & Dose Controller

The dose controller activates I-Bresis and Standard Modes. The delivery flexibility allows clinicians to select the perfect treatment combination for each individual patient. The charging station keeps the dose controllers charged between uses. Simply remove a wireless dose controller whenever a patch requires activation.